Pasquale DiCapo Acquires Common Shares of AMI Resources Inc.

Posted In: Materials

By The Associated Press

Wednesday, November 4, 2009

Loading...

Mr. Pasquale DiCapo ("DiCapo"), 130 King Street West, Suite 2500, Toronto, Ontario M5X 1A9 announces that on October 30, 2009, he acquired ownership of 1,000,000 common shares ("Common Shares") of AMI Resources Ltd. ("AMI") and 500,000 common share purchase warrants (the "Warrants") (each Warrant entitling the holder thereof to acquire one additional Common Share at a price of $0.20 until April 28, 2011) which securities were acquired by DiCapo directly. As of October 30, 2009, these holdings represent approximately 2.12% of the issued and outstanding Common Shares (or approximately 3.14% on a partially diluted basis, assuming exercise of the Warrants only). In addition, as at October 30, 2009, joint actors of DiCapo acquired ownership and control of 850,000 broker warrants (together with an additional 425,000 convertible securities underlying such broker warrants) of AMI (collectively, the "Joint Actor Securities"), which (i) represents approximately 2.63% of the issued and outstanding Common Shares as of October 30, 2009 on a partially diluted basis, assuming exercise of the Joint Actor Securities only; and (ii) when taken together with the securities of DiCapo, represent approximately 2.12% of the issued and outstanding Common Shares as of October 30, 2009 (or approximately 5.67% on a partially diluted basis, assuming exercise of the Warrants and Joint Actor Securities only).

Immediately following the transaction noted above, DiCapo owns: (i) 2,750,000 Common Shares which are owned by DiCapo directly; and (ii) 1,500,000 warrants (including the Warrants) (collectively the "Aggregate Warrants"), which are owned by DiCapo directly. Such securities represent approximately 5.83% of the issued and outstanding Common Shares as of October 30, 2009 (or approximately 8.73% on a partially diluted basis, assuming exercise of the Aggregate Warrants only). In addition, as at October 30, 2009, joint actors of DiCapo own 1,170,000 broker warrants (together with an additional 745,000 convertible securities underlying such broker warrants) of AMI (collectively, the "Joint Actor Aggregate Securities"), (i) representing approximately 3.9% of the issued and outstanding Common Shares as of October 30, 2009 on a partially diluted basis, assuming exercise of the Joint Actor Aggregate Securities only; and (ii) when taken together with the securities owned by DiCapo, represent approximately 5.83% of the issued and outstanding Common Shares as of October 30, 2009 (or approximately 12.18% on a partially diluted basis, assuming exercise of the Aggregate Warrants and the Joint Actor Aggregate Securities only).

DiCapo acquired the Common Shares and Warrants pursuant to a subscription agreement dated October 30, 2009 between AMI and the Offeror for aggregate gross proceeds of $100,000 ($0.10 per unit, each unit consisting of one common share and one-half of one Warrant). The joint actor received the Joint Actor Securities for acting as a finder for the financing. The Common Shares and Warrants were acquired pursuant to National Instrument 45-106 section 2.3. DiCapo is an "accredited investor" as defined in the applicable securities laws.

These transactions were made for investment purposes and DiCapo and his joint actors could increase or decrease their respective investments in AMI depending on market conditions or any other relevant factor.

To obtain a copy of the report filed pursuant to applicable securities regulations in connection with the foregoing, please contact: Shaun Drake Tel: 416-848-0107 Fax: 416-848-0790 sdrake@dsacorp.ca (mailto:sdrake@dsacorp.ca) 50 Richmond Street East, Suite 101, Toronto, ON M5C 1N7

JOIN THE DISCUSSION
Rate Article:  Average 0 out of 5
Register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

New To Market

more

Infrared imaging in radiation free scanner for security

Iscon Video Imaging is introducing two new airport passenger scanners with a patented Thermal-Boosted Infrared Detection System that only shows objects and clothing without any harmful radiation.

First commercial 3-D bio-printer makes human tissue and organs

Invetech, a builder of custom automation for the biomedical, industrial and consumer markets, has delivered the world's first production model 3-D bio-printer to Organovo, developers of the proprietary NovoGen bioprinting technology.

Tools & Technology

more

Software for drug optimization
Software for drug optimization

Optibrium launched StarDrop 4.3. The intuitive software offers advantages over traditional predictive modeling platforms as it helps users to identify chemistries with a high chance of success and focus expensive in-house resources.

LED light site for LED solutions

The new LED Light Site from OSRAM Opto Semiconductors is a source of LED information, resources, tools, technology, and LED lighting solutions for the solid state lighting and general illumination spaces.

Advertisement

Advertisement